NEUROLUX, INC.

Biotech · Private

Multi-electrode array and optogenetic interface with soft robotic actuators for measuring and modulating neural organoid activity

Grants
$11M
16 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · Low cost, fully implantable wireless optoeletronic devices for optogenetics research$750,000
Federal grantDepartment of Health and Human Services · Phase I · Wireless, implantable optofluidic systems for programmed pharmacology and optogenetics$149,610
Federal grantDepartment of Health and Human Services · Phase II · Low cost, fully implantable wireless optoeletronic devices for optogenetics research$735,500
Federal grantDepartment of Health and Human Services · Phase I · Wireless Implantable Neural Recording Device$220,091
Federal grantDepartment of Health and Human Services · Phase II · Wireless, implantable optofluidic systems for programmed pharmacology and optogenetics$694,703
Federal grantDepartment of Health and Human Services · Phase II · Wireless, implantable optofluidic systems for programmed pharmacology and optogenetics$663,443
Federal grantDepartment of Health and Human Services · Phase II · Advanced wireless optogenetics and photometry system for neuroscience research$993,022
Federal grantDepartment of Health and Human Services · Phase II · Low Cost, Fully Implantable Wireless Neural Recording Device$748,082
Federal grantDepartment of Health and Human Services · Phase II · Advanced wireless optogenetics and photometry system for neuroscience research$995,447
Federal grantDepartment of Health and Human Services · Phase II · Low Cost, Fully Implantable Wireless Neural Recording Device$721,617
Federal grantDepartment of Health and Human Services · Phase II · Advanced wireless optogenetics and photometry system for neuroscience research$991,491
Federal grantDepartment of Health and Human Services · Phase I · Wireless Implantable Mechano-Acoustic Recording Device$259,612
Federal grantDepartment of Health and Human Services · Phase II · Wireless Implantable Mechano-Acoustic Recording Device$986,327
Federal grantDepartment of Health and Human Services · Phase II · Wireless Implantable Mechano-Acoustic Recording Device$966,320
Federal grantDepartment of Health and Human Services · Phase I · Electromechanically monitored engineered heart tissue platform$525,824
Federal grantDepartment of Health and Human Services · Phase I · Development and Validation of a Compliant Reversible Actuator and Detector Leveraging Electrophysiology for Organoids (Organoid-CRADLE)$499,781
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3093MADELEINE PHARMACEUTICALS, INC.——
3094AGYPHARMA, LLC——
3095TINY CARGO COMPANY, THE——
3096NEUROLUX, INC.——
3097NEW YORK/R&D/CTR/TRANSLATIONAL MED/THER——
3098ImmPORT Therapeutics Inc dba Antigen Discovery Inc——
3099ASSUAGE PHARMACEUTICALS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.